Assessing the validity of an ELISA test for the serological diagnosis of human fascioliasis in different epidemiological situations

Tropical Medicine and International Health

Volumn 17, Issue 5, 2012, Pages 630-636

  Adela Valero, M ^a   Victoria Periago, M ^a   Pérez Crespo, Ignacio ^a   Rodríguez, Esperanza ^b   Jesus Perteguer M ^b   Gárate, Teresa ^b   González Barberá, Eva M ^c   Mas Coma, Santiago ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

ELISA; Fasciola gigantica; Fasciola hepatica; IgG; Sensitivity and specificity; Serodiagnosis

Indexed keywords

CATHEPSIN L; IMMUNOGLOBULIN G; PARASITE ANTIGEN;

ASSESSMENT METHOD; BIOASSAY; CORRELATION; EGG; ENZYME ACTIVITY; EPIDEMIOLOGY; INFECTIVITY; PARASITIC DISEASE; SENSITIVITY ANALYSIS;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FASCIOLA GIGANTICA; FASCIOLA HEPATICA; FASCIOLIASIS; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARASITE SERODIAGNOSIS; SENSITIVITY AND SPECIFICITY; VALIDITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; ENDEMIC DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASCIOLIASIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SPAIN; YOUNG ADULT;

FASCIOLA; FASCIOLA GIGANTICA; FASCIOLA HEPATICA; VERMES;

EID: 84860004669     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2012.02964.x     Document Type: Article

References (38)

1. Ashrafi K, Valero MA, Panova M, Periago MV, Massoud J & Mas-Coma S (2006) Phenotypic analysis of adults of Fasciola hepatica, Fasciola gigantica and intermediate forms from the endemic region of Gilan, Iran. Parasitology International 55, 249-260.
2. Brady MT, O'Neill SM, Dalton JP & Mills KH (1999) Fasciola hepatica supresses a protective Th1 response against Bordetella pertussis. Infection and Immunity 67, 5372-5378.
3. Carnevale S, Rodriguez MI, Guarnera EA, Carmona C, Tanos T & Angel SO (2001) Immunodiagnosis of fasciolosis using recombinant procathepsin L cystein proteinase. Diagnostic Microbiology and Infectious Disease 41, 43-49.
4. Cornejo H, Oblitas F, Cruzado S & Quispe W (2010) Evaluation of an ELISA test with Fasciola hepatica metabolic antigen for diagnosis of human fascioliasis in Cajamarca, Peru. Revista Peruana de Medicina Experimental y Salud Publica 27, 569-574.
5. Demerdash ZA, Diab TM, Aly IR et al. (2011) Diagnostic efficacy of monoclonal antibody based sandwich enzyme linked immunosorbent assay (ELISA) for detection of Fasciola gigantica excretory/secretory antigens in both serum and stool. Parasites & Vectors 4, 176.
6. Espinoza JR, Maco V, Marcos L et al. (2007) Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans. American Journal of Tropical Medicine and Hygiene 76, 977-982.
7. Figueroa-Santiago O, Delgado B & Espino AM (2011) Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis. Diagnostic Microbiology and Infectious Disease 70, 355-361.
8. Fletcher RH & Fletcher SW (2005) Fourth Edition Clinical Epidemiology. The Essentials. Lippincott Williams & Wilkins, Baltimore, MD. Chapter 3. Diagnosis pp. 35-58.
9. Gironès N, Valero MA, García-Bodelón MA et al. (2007) Immune suppression in advanced chronic fascioliasis: an experimental study in a rat model. Journal of Infectious Diseases 195, 1504-1512.
10. Hillyer GV (1999) Immunodiagnosis of human and animal fasciolosis. In: Fasciolosis (ed. J.P. Dalton ) CABI Publishing, Oxon, UK, pp. 435-447.
11. Intapan PM, Tantrawatpan C, Maleewong W, Wongkham S, Wongkham C & Nakashima K (2005) Potent epitopes derived from Fasciola gigantica cathepsin L1 in peptide-based immunoassay for the serodiagnosis of human fascioliasis. Diagnostic Microbiology and Infectious Disease 53, 125-129.
12. Le TH, De NV, Agatsuma T et al. (2007) Molecular confirmation that Fasciola gigantica can undertake aberrant migrations in human hosts. Journal of Clinical Microbiology 45, 648-650.
13. Martínez-Sernández V, Muiño L, Perteguer MJ et al. (2011) Development and evaluation of a new lateral flow immunoassay for serodiagnosis of human fasciolosis. PLoS Neglected Tropical Diseases 5, e1376.
14. Mas-Coma S, Bargues MD & Esteban JG (1999) Human fasciolosis. In: Fasciolosis (ed JP Dalton ) CABI Publishing, Oxon, UK, pp. 411-434.
15. Mas-Coma S, Bargues MD & Valero MA (2005) Fascioliasis and other plant-borne trematode zoonoses. International Journal of Parasitology 35, 1255-1278.
16. Mas-Coma S, Valero MA & Bargues MD (2009a) Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Advances in Parasitology 69, 41-146.
17. Mas-Coma S, Valero MA & Bargues MD (2009b) Climate change effects on trematodiases, with emphasis on zoonotic fascioliasis and schistosomiasis. Veterinary Parasitology 163, 264-280.
18. Mezo M, González-Warleta M & Ubeira FM (2003) Optimized serodiagnosis of sheep fascioliasis by Fast-D protein liquid chromatography fractionation of Fasciola hepatica excretory-secretory antigens. Journal of Parasitology 89, 843-849.
19. Mezo M, González-Warleta M, Carro C & Ubeira FM (2004) An ultrasensitive capture ELISA for detection of Fasciola hepatica coproantigens in sheep and cattle using a new monoclonal antibody (MM3). Journal of Parasitology 90, 845-852.
20. Mezo M, González-Warleta M & Ubeira FM (2007) The use of MM3 monoclonal antibodies for the early immunodiagnosis of ovine fascioliasis. Journal of Parasitology 93, 65-72.
21. Mezo M, González-Warleta M, Castro-Hermida JA, Muiño L & Ubeira FM (2010) Field evaluation of the MM3-SERO ELISA for detection of anti-Fasciola IgG antibodies in milk samples from individual cows and bulk milk tanks. Parasitology International 59, 610-615.
22. Muiño L, Perteguer MJ, Gárate T et al. (2011) Molecular and immunological characterization of Fasciola antigens recognized by the MM3 monoclonal antibody. Molecular and Biochemical Parasitology 179, 80-90.
23. O'Neill SM, Parkinson M, Strauss W, Angles R & Dalton JP (1998) Immunodiagnosis of Fasciola hepatica infection (Fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase. American Journal of Tropical Medicine and Hygiene 58, 417-423.
24. O'Neill SM, Parkinson M, Dowd AJ, Strauss W, Angles R & Dalton J (1999) Short report: Immunodiagnosis of human fascioliasis using recombinant Fasciola hepática cathepsin L1 cysteine proteinase. American Journal of Tropical Medicine and Hygiene 60, 749-751.
25. Periago MV, Valero MA, El Sayed M et al. (2008) First phenotypic description of Fasciola hepatica/Fasciola gigantica intermediate forms from the human endemic area of the Nile Delta, Egypt. Infection, Genetics and Evolution 8, 51-58.
26. Rahimi MT, Ashrafi K, Koosha S, Abdi J & Rokni MB (2011) Evaluation of Fast-ELISA versus standard-ELISA to diagnose human fasciolosis. Archives of Iranian Medicine 14, 18-21.
27. Rokni MB, Massoud J, O'Neill SM, Parkinson M & Dalton JP (2002) Diagnosis of human fasciolosis in the Gilan province of Northern Iran: application of cathepsin L-ELISA. Diagnostic Microbiology and Infectious Disease 44, 175-179.
28. Salimi-Bejestani MR, McGarry JW, Felstead S, Ortiz P, Akca A & Williams DJ (2005) Development of an antibody-detection ELISA for Fasciola hepatica and its evaluation against a commercially available test. Research in Veterinary Science 78, 177-181.
29. Sánchez-Andrade A, Suárez JL, Arias M et al. (2008) Relationships between eosinophilia, anti-Fasciola IgG, and IgM rheumatoid factors, in urban and rural areas of north-western Spain. Annals of Tropical Medicine and Parasitology 102, 489-498.
30. Valero MA, Varea MT & Marín R (2000) Fasciola hepatica: lithogenic capacity in experimentally infested rats and chemical determination of the main stone components. Parasitology Research 86, 558-562.
31. Valero MA, Santana M, Morales M, Hernandez JL & Mas-Coma S.S. (2003) Risk of gallstone disease in advanced chronic phase of fascioliasis: an experimental study in a rat model. Journal of Infectious Diseases 188, 787-793.
32. Valero MA, Navarro M, Garcia-Bodelon MA et al. (2006) High risk of bacterobilia in advanced experimental chronic fascioliasis. Acta Tropica 100, 17-23.
33. Valero MA, Gironès N, García-Bodelón MA et al. (2008) Anaemia in advanced chronic fascioliasis. Acta Tropica 108, 35-43.
34. Valero MA, Perez-Crespo I, Periago MV, Khoubbane M & Mas-Coma S (2009a) Fluke egg characteristics for the diagnosis of human and animal fascioliasis by Fasciola hepatica and F. gigantica. Acta Tropica 111, 150-159.
35. Valero MA, Ubeira FM, Khoubbane M et al. (2009b) MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica. Veterinary Parasitology 159, 77-81.
36. WHO (2007) Report of the WHO Informal Meeting on use of triclabendazole in fascioliasis control. World Health Organization, Headquarters Geneva, 17-18 October 2006: WHO/CDS/NTD/PCT/2007.1.
37. WHO (2008) Fact sheet on fascioliasis. In: Action Against Worms, World Health Organization, Headquarters Geneva (December 2007), Newsletter 10, pp. 1-8.
38. Wongkham C, Tantrawatpan C, Intapan PM, Maleewong W, Wongkham S & Nakashima K (2005) Evaluation of immunoglobulin G subclass antibodies against recombinant Fasciola gigantica cathepsin L1 in an enzyme-linked immunosorbent assay for serodiagnosis of human fasciolosis. Clinical and Diagnostic Laboratory Immunology 12, 1152-1156.